2:00PM Advancing Immunogenicity Risk Assessment in AAV Gene Therapy
Time: 2:00 pm
day: Conference Day 1
Details:
• Unraveling the complexities of immune response to AAV vectors
• Determinants of AAV immunogenicity
• Impact of pre-existing immunity on AAV immunogenicity; including case studies
• Cutting-edge strategies to counteract AAV immunogenicity with insights from in vitro explorations
